Veru Inc (VERU) Stock: What Does the Chart Say Monday?

Veru Inc (VERU) stock has fallen 7.02% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Veru Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VERU!

See Full VERU Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With VERU Stock Today?

Veru Inc (VERU) stock is down -2.31% while the S&P 500 is up 0.15% as of 10:42 AM on Monday, Aug 21. VERU is down -$0.03 from the previous closing price of $1.08 on volume of 210,346 shares. Over the past year the S&P 500 is higher by 5.76% while VERU is down -93.75%. VERU lost -$1.38 per share in the over the last 12 months.

More About Veru Inc

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. Click Here to get the full Stock Report for Veru Inc stock.